Debajit Sen Sharma is appointed as Group Chief financial officer of Paras healthcare today.
He will take care of strategising company’s growth and expansion plans.
He has a vast experience of 28 years in the field of finance and accounts. Formerly, he was associated with some healthcare and pharma majors, namely as Ranbaxy Laboratories Ltd, Sentiss Pharma Pvt Ltd, Symbiotec Pharma lab Pvt. Ltd, and others.
“We are delighted to have Debajit join our team. His expertise in financial planning and budgeting, mergers and acquisitions, fund raising, business structuring, and investment planning will be much needed to further our expansion plans and direct healthcare delivery operations towards newer areas,” said Dr Dharminder Nagar, MD, Paras Healthcare.
“I am excited about my new role at Paras Healthcare, which has been at the forefront of quality medical care delivery to the common man. My endeavors would be to put to use my experience in pharma and healthcare industry and further Dr. Nagar’s plans for the organization,” said Debajit Sen Sharma on his appointment.
Paras healthcare also announced the launch of Paras Sarthi—a healthcare delivery platform based on a CSR funding-focused aggregator model to provide quality medical care services to the needy and underprivileged in the month of August 2018.